Corin Group plc (US Headquarters) Extends Losses As FDA Staff Question Study
LONDON, Feb 21 (Reuters) - Corin Group Plc (CRG.L: Quote, Profile , Research) shares fell more than 11 percent on Wednesday, extending earlier losses on concerns a U.S. advisory panel meeting on Feb. 22 might not endorse its new Cormet hip-resurfacing system.